ABT-712
Sponsors
AbbVie (prior sponsor, Abbott)
Conditions
Chronic Low Back Pain
Phase 3
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
CompletedNCT00761150
Start: 2008-09-30End: 2009-03-31Updated: 2014-02-07
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
CompletedNCT00763321
Start: 2008-09-30End: 2009-04-30Updated: 2014-02-06